GL1X · GenesisL1 explorer

MolNFT v1 · #117179 · protein

1.95 a resolution structure of norovirus 3CL protease in complex with a triazole-based macrocyclic (18-mer) inhibitor

5E0H · Norovirus 3C-like protease: “1.95 a resolution structure of norovirus 3CL protease in complex with a triazole-based macrocyclic (18-mer)…”. X-ray diffraction, 1 ligand (5LH), 1 pocket (best druggability 0.66). MolNFT v1 #117179 on…

PDB
5E0H
Type
protein
Length
327 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Norovirus 3C-like protease
EC
3.4.22.66
UniProt
Q83883
Ligands
5LH
Pockets
1 · best druggability 0.66

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANorovirus 3C-like protease (EC 3.4.22.66)protein1668% helix, 52% strandQ83883
BNorovirus 3C-like protease (EC 3.4.22.66)protein1616% helix, 52% strandQ83883

Ligands and binding sites

  • 5LH · (phenylmethyl) ~{N}-[(9~{S},12~{S},15~{S})-9-(hydroxymethyl)-12-(2-methylpropyl)-6,11,14-tris(oxidanylidene)-1,5,10,13,18,19-hexazabicyclo[15.2.1]icosa-17(20),18-dien-15-yl]carbamate · ligand · chains A
  • GOL · Glycerol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12510.660.8328GOL

Interfaces

1 interface between chains.

  • A–B · 447 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide, 1 covalent (disulfide, covalent ligand).

Compared structures

  • 5E0H · 1.95 A resolution structure of Norovirus 3CL protease in complex with a triazole-based… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.